Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193232
Status:
COMPLETED
Last Update Posted:
2010-07-28
First Post:
2005-09-12
Brief Title:
Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |
Keywords: